Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D G Haller

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|December 31, 1998
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancerD P Kelsen, R Ginsberg, T F Pajak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B StudyP J O'Dwyer, J Manola, F H Valone, et al.
Cancer|June 22, 1999
The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care StudyL R Coia, B D Minsky, M J John, et al.
The New England Journal of Medicine|September 8, 2001
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junctionJ S Macdonald, S R Smalley, J Benedetti, et al.
Journal of Surgical Oncology|April 20, 2007
Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancerC M Dolinsky, N N Mahmoud, R Mick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2015
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†L A Renfro, A Grothey, D Kerr, et al.
Annals of Internal Medicine|March 1, 1995
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final reportC G Moertel, T R Fleming, J S Macdonald, et al.
ESMO Open|March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysisR Cohen, M Raeisi, B Chibaudel, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1995
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancerC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|February 8, 1990
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinomaC G Moertel, T R Fleming, J S Macdonald, et al.
The New England Journal of Medicine|December 31, 1998
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancerD P Kelsen, R Ginsberg, T F Pajak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B StudyP J O'Dwyer, J Manola, F H Valone, et al.
Cancer|June 22, 1999
The evaluation and treatment of patients receiving radiation therapy for carcinoma of the esophagus: results of the 1992-1994 Patterns of Care StudyL R Coia, B D Minsky, M J John, et al.
The New England Journal of Medicine|September 8, 2001
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junctionJ S Macdonald, S R Smalley, J Benedetti, et al.
Journal of Surgical Oncology|April 20, 2007
Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancerC M Dolinsky, N N Mahmoud, R Mick, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2015
Survival following early-stage colon cancer: an ACCENT-based comparison of patients versus a matched international general population†L A Renfro, A Grothey, D Kerr, et al.
Annals of Internal Medicine|March 1, 1995
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final reportC G Moertel, T R Fleming, J S Macdonald, et al.
ESMO Open|March 5, 2025
Impact of tumor and node stages on the efficacy of adjuvant oxaliplatin-based chemotherapy in stage III colon cancer patients: an ACCENT pooled analysisR Cohen, M Raeisi, B Chibaudel, et al.
Pageof 9